IGM stock crashed Tuesday after the biotech company scrapped development of a cancer drug and announced three of its executives stepped down.
The post Top 1% Biotech, IGM Biosciences, Plummets On Scrapped Drug, C-Suite Makeover appeared first on Investor’s Business Daily.